Lataa...
Plasma pharmacokinetics of high-affinity transferrin receptor antibody-erythropoietin fusion protein is a function of effector attenuation in mice
Erythropoietin (EPO) is a potential therapeutic for Alzheimer’s disease (AD), however limited blood-brain barrier (BBB) penetration reduces its applicability as a CNS therapeutic. Antibodies against the BBB transferrin receptor (TfRMAbs) act as molecular Trojan horses for brain drug delivery, and a...
Tallennettuna:
| Julkaisussa: | Mol Pharm |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6684820/ https://ncbi.nlm.nih.gov/pubmed/31199881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.molpharmaceut.9b00369 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|